Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -12.96 | -18.81 |
PEG Ratio (TTM) | 4.15 | -5.53 |
P/S Ratio (TTM) | 1,250.15 | 47.66 |
P/B Ratio (TTM) | 1.60 | 31.59 |
P/FCF Ratio (TTM) | -15.92 | -3.70 |
Price to 5YR AVG Earnings Ratio | N/A | -7.63 |
Price to 5YR AVG FCF Ratio | N/A | -14.42 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -11.86% | -16.98% |
ROE (TTM) | -16.40% | 27.27% |
Net Profit Margin (TTM) | -8,324.91% | -682.28% |
ROIC 5YR AVG | N/A | -3.58% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -3.99% | -46,708.10% | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | -9.86% | -44,998.54% | N/A |
Cash Flow | -3.52% | -47,835.16% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 27.63 | 5.71 |
Quick Ratio (TTM) | 27.63 | 5.49 |
D/E Ratio (TTM) | N/A | 1.09 |
Interest Coverage (TTM) | -9.14 | -7.46 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | 27.76 | 12.74 |
LTL to 5YR AVG FCF | N/A | 0.06 |
Shares Outstanding Growth 5YR AVG | N/A | 40.20% |